Union Bancaire Privee’s Regeneron Pharmaceuticals REGN Stock Holding History

Union Bancaire Privee’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$351K	Sell	571 -3,803	-87%	-$2.59M	﹤0.01%	362
2026 Q1	$3.2M	Buy	4,374 +381	+10%	+$292K	0.04%	177
2025 Q4	$3.02M	Buy	3,993 +3,476	+672%	+$2.36M	0.04%	187
2025 Q3	$232K	Buy	+517	New	+$292K	﹤0.01%	368
2025 Q1	–	Sell	-5	Closed	-$2.81K	–	559
2024 Q4	$2.81K	Buy	+5	New	+$4.2K	﹤0.01%	553

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Union Bancaire Privee's REGN Position: Q2 2026 in Review

Union Bancaire Privee reduced its Regeneron Pharmaceuticals (REGN) stake by 87% in Q2 2026, selling an estimated $2.59M and leaving 571 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #362.

Union Bancaire Privee first reported a position in REGN in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.2M in Q1 2026. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Union Bancaire Privee held 571 shares of Regeneron Pharmaceuticals worth $351K as of Q2 2026.
Union Bancaire Privee sold 3,803 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.59M.
Regeneron Pharmaceuticals made up ﹤0.01% of Union Bancaire Privee's portfolio in Q2 2026, its #362 holding.
Union Bancaire Privee first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
Union Bancaire Privee's Regeneron Pharmaceuticals position peaked at $3.2M in Q1 2026.
518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.